RopesTalk

On this episode of the R&G Tech Studio podcast, host Andrew Radsch, intellectual property litigation partner and lead of Ropes & Gray’s semiconductor sector, sits down with Rachael Bacha, counsel in the firm’s IP litigation group. Rachael, who boasts a dual background in genetics and computer science, discusses her evolution within the firm and her specialized focus on intellectual property damages. The conversation covers the intricacies of damages in patent litigation, the effects of globalization on IP infringement cases, and some of the landmark court decisions that have helped shape the practice. Additionally, Rachael offers insights into the use of AI in legal processes and the future of technology in IP law. 

Stephanie Niven, a portfolio manager at Ninety One, dives into the crucial link between corporate culture and investment returns. She emphasizes the importance of diversity, equity, and inclusion in driving performance and explores how traditional metrics often miss the value of a positive culture. Niven also discusses the structural best practices that foster a supportive work environment and the need for a blend of qualitative and quantitative methods to measure culture effectively. The conversation highlights corporate culture as a competitive advantage in the evolving landscape of sustainable investing.

On this Ropes & Gray podcast, asset management partners Chelsea Childs and Catherine Skulan discuss considerations for private fund managers seeking to explore the expansion of their business into alternative retail products. They share insights on the benefits of accessing a broader investor base, highlight alternative fund types—interval funds and tender offer funds—that are more suited to private investment strategies and discuss key considerations for managers looking to break into the registered funds space. 

Join Deb Lussier, partner and co-leader of the sponsor solutions practice at Ropes & Gray, on the latest episode of A Word for Our Sponsors. On this podcast, the second in a two-part series, Deb and Marc Migliazzo, counsel in the sponsor solutions practice, continue their in-depth conversation with Jon Costello, founder and managing partner of Devon Park Advisors, about the dynamic GP-led secondary market. They delve into the role of new entrants, the impact of single-family offices and sovereign wealth funds, and the future of continuation funds. The discussion also explores the trends affecting management teams and the potential for sponsors to hold assets long-term. 

Join Deb Lussier, partner and co-leader of the sponsor solutions practice at Ropes & Gray, and Marc Migliazzo, counsel in the sponsor solutions practice, as they delve into the dynamic world of GP-led secondary transactions with special guest Jon Costello, founder and managing partner of Devon Park Advisors, a boutique investment bank with a core focus on continuation fund transactions. On this episode of A Word for Our Sponsors, the first in a two-part podcast series, they discuss the current market trends, the history and future of continuation fund transactions, and the perspectives of both sponsors and limited partners. Gain valuable insights into the strategic considerations for executing successful GP-led secondaries and the importance of early engagement and clear communication in these deals. 

On this episode of the R&G Tech Studio podcast, Matt Shapiro discusses the latest trends in technology litigation, focusing on the automotive industry. He delves into the impact of vehicle-to-everything (V2X) communications, electric vehicle (EV) technologies, and autonomous driving on leading technology companies. He also discusses the global implications of the Unified Patent Court (UPC) and standard essential patent (SEP) litigation.

In this discussion, Ryan Rohlfsen, a partner at Ropes & Gray and former DOJ prosecutor, shares his insights on the Foreign Extortion Prevention Act (FEPA). He explains how FEPA could transform anti-corruption enforcement and corporate compliance, highlighting risks for businesses operating internationally. The conversation dives into the cultural nuances of bribery perceptions across different jurisdictions, and the role of whistleblowers in shaping compliance practices. With a blend of legal expertise and practical challenges, Rohlfsen provides a compelling look at the future of anti-corruption strategies.

On this episode of Women @ RopesTalk hosted by IP transactions partner Megan Baca, litigation & enforcement partner Helen Gugel returns for another engaging conversation, this time with Neena Reddy, general counsel of Blue Owl Capital, an alternative asset manager with nearly $200 billion in assets under management. Neena shares her journey from private practice to in-house counsel, detailing the exponential growth of Blue Owl, the challenges and strategies of managing legal affairs for a global firm, and her role in fostering a culture of women supporting women. The conversation also delves into Neena's multifaceted role, her approach to leadership, and her personal insights on work-life balance and the importance of networking in the legal industry. 

On this episode of Non-binding Guidance, hear from Kellie Combs, chair of Ropes & Gray’s life sciences regulatory and compliance practice group, and Josh Oyster, a nationally recognized partner in the life sciences regulatory and compliance practice, as they discuss the FDA’s revised draft guidance, "Addressing Misinformation About Medical Devices and Prescription Drugs: Questions and Answers." They address key changes from the FDA’s prior draft guidance, potential challenges in implementing the FDA’s recommendations, and how the new guidance fits within the FDA’s overall framework for medical product manufacturer communications. 

On this episode of Ropes & Gray’s podcast series, Controlling Opinions, hear from partners Brett Friedman, Andrew O’Connor, and Josh Oyster regarding recent developments related to the prescribing of controlled substances via telemedicine. They discuss the current DEA regulatory landscape related to prescriptions of controlled substances via telemedicine and explore the implications of a recently announced prosecution in which the Department of Justice alleged that executives at a digital health company wrongfully distributed controlled substances via telemedicine.